Attached files
| file | filename |
|---|---|
| EX-3.1 - AMENDED AND RESTATED ARTICLES - InMed Pharmaceuticals Inc. | f10q0920ex3-1_inmed.htm |
| EX-31.1 - CERTIFICATION - InMed Pharmaceuticals Inc. | f10q0920ex31-1_inmed.htm |
| EX-31.2 - CERTIFICATION - InMed Pharmaceuticals Inc. | f10q0920ex31-2_inmed.htm |
| EX-32.2 - CERTIFICATION - InMed Pharmaceuticals Inc. | f10q0920ex32-2_inmed.htm |
| 10-Q - QUARTERLY REPORT - InMed Pharmaceuticals Inc. | f10q0920_inmedpharma.htm |
Exhibit 32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Eric A. Adams, the President and Chief Executive Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 16, 2020
| /s/ Eric A. Adams | |
| Name: Eric A. Adams | |
| Title: President and Chief Executive Officer |